The deadline for health and wellbeing grant applications to help people with cystic fibrosis (CF) improve their health and quality of life is approaching.
As the National Institute for Health and Care Excellence (NICE) opts not to recommend the gene-specific medicine Orkambi to NHS England, while acknowledging the clinical benefits of the drug, the Cystic Fibrosis Trust has put forward a solution that could speed up access and evaluation.